A Mathematical Modeling Approach to Understanding the Effect of Anti-Interleukin Therapy on Eosinophils.

about

Eosinophil Activation Status in Separate Compartments and Association with Asthma Methodologies for Quantitative Systems Pharmacology (QSP) Models: Design and Estimation.Interleukin-13 in Asthma and Other Eosinophilic Disorders.

P2860

Q33785627-46E9799C-5A5E-46D1-B357-B5ACE1AC62AE Q42350410-FC73C42B-E2F0-4B4D-9DD8-02B24705A109 Q42369958-F8DB5D05-6C2B-484B-9D7E-93B3C4D85AE8

P2860

A Mathematical Modeling Approach to Understanding the Effect of Anti-Interleukin Therapy on Eosinophils.

Item

http://www.wikidata.org/entity/Q40067123

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

A Mathematical Modeling Approa ...... leukin Therapy on Eosinophils.

@en

type

Item

label

A Mathematical Modeling Approa ...... leukin Therapy on Eosinophils.

@en

prefLabel

A Mathematical Modeling Approa ...... leukin Therapy on Eosinophils.

@en

P1476

A Mathematical Modeling Approa ...... leukin Therapy on Eosinophils.

@en

P2093

B M Agoram

http://www.w3.org/2001/XMLSchema#string

G Colice

http://www.w3.org/2001/XMLSchema#string

O Demin

http://www.w3.org/2001/XMLSchema#string

V Voronova

http://www.w3.org/2001/XMLSchema#string

P2860

Preclinical development of CAT-354, an IL-13 neutralizing antibody, for the treatment of severe uncontrolled asthma

A novel IL-1 family cytokine, IL-33, potently activates human eosinophils

Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion

A functional study on CysLT(1) receptors in human eosinophils

Reslizumab for Poorly Controlled, Eosinophilic Asthma

DBSolve Optimum: a software package for kinetic modeling which allows dynamic visualization of simulation results

Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies.

Targeting interleukin-13 with tralokinumab attenuates lung fibrosis and epithelial damage in a humanized SCID idiopathic pulmonary fibrosis model.

IL-13 and the IL-13 receptor as therapeutic targets for asthma and allergic disease.

Lebrikizumab treatment in adults with asthma.

P304

608-616

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PSP4.12129

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

T Karelina

P577

2016-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27885827

http://www.w3.org/2001/XMLSchema#string

P921

interleukin

P932

5192997

http://www.w3.org/2001/XMLSchema#string

A Mathematical Modeling Approach to Understanding the Effect of Anti-Interleukin Therapy on Eosinophils.

about

P2860

P2860

A Mathematical Modeling Approach to Understanding the Effect of Anti-Interleukin Therapy on Eosinophils.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932